Various disulfiram formulations decreased MGMT abundance in GBM cells via the ubiquitin–proteasome pathway by modifying a cysteine residue, resulting in an increase in alkylator-induced cytotoxicity [66]. This evidence concerns the gene MGMT and glioblastoma.